Prophylactic HPV Vaccines for Cervical Cancer
Series: Oxford American Pocket Cards;
- Publisher's listprice GBP 5.99
-
2 861 Ft (2 725 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 286 Ft off)
- Discounted price 2 575 Ft (2 453 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
2 861 Ft
Availability
cancelled
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 30 September 2010
- ISBN 9780199767298
- Binding Other published material
- No. of pages1 pages
- Weight 100 g
- Language English 0
Categories
Long description:
Cervical cancer is the second most common form of cancer found in women, and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human pailloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and how
cervical cnancer screening will change following vaccination.
Part of the Oxford American Pocket Card series, the information for this small card was taken from Vaccines for the Prevention of Cervical Cancer (edited by PL Stern and KC Kitchener). It is designed to be an educational brochure on the prophylactic HPV vaccines for cervical cancer. The card includes an overview of the role of HPV in the pathology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the
challenges of implementing HPV vaccines and future developments. Figures and tables are included to enhance reader understanding.
